Literature DB >> 2685048

Review: assessment of complement activation in clinical immunology laboratories: time for reappraisal?

M Peakman1, G Senaldi, D Vergani.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2685048      PMCID： PMC501857          DOI： 10.1136/jcp.42.10.1018

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  78 in total

Review 1.  Methods to detect and quantitate complement activation.

Authors:  N R Cooper; G R Nemerow; J T Mayes
Journal:  Springer Semin Immunopathol       Date:  1983

Review 2.  Relationships among the complement, kinin, coagulation, and fibrinolytic systems.

Authors:  J S Sundsmo; D S Fair
Journal:  Springer Semin Immunopathol       Date:  1983

3.  Mediation of proteinuria in membranous nephropathy due to a planted glomerular antigen.

Authors:  S Adler; D J Salant; J E Dittmer; H G Rennke; M P Madaio; W G Couser
Journal:  Kidney Int       Date:  1983-06       Impact factor: 10.612

4.  Radioimmunoassay for anaphylatoxins: a sensitive method for determining complement activation products in biological fluids.

Authors:  J L Wagner; T E Hugli
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

5.  Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.

Authors:  J T Mayes; R D Schreiber; N R Cooper
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

6.  The third complement factor (C3) and its in vivo cleavage products: interaction with lectins and precipitation with polyethylene glycol.

Authors:  B Teisner; J Hau; S E Svehag; I Brandslund; T C Bøg-Hansen
Journal:  J Immunol Methods       Date:  1984-01-20       Impact factor: 2.303

7.  Clinical application of a new nephelometric technique to measure complement activation.

Authors:  D Vergani; L Bevis; B A Nasaruddin; G Mieli-Vergani; D E Tee
Journal:  J Clin Pathol       Date:  1983-07       Impact factor: 3.411

8.  The use of C3d as a means of monitoring clinical activity in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  W J Morrow; D J Williams; C Ferec; R Casburn-Budd; D A Isenberg; E Paice; M L Snaith; P Youinou; P Le Goff
Journal:  Ann Rheum Dis       Date:  1983-12       Impact factor: 19.103

9.  Role of the terminal complement pathway in experimental membranous nephropathy in the rabbit.

Authors:  G C Groggel; S Adler; H G Rennke; W G Couser; D J Salant
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

10.  Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility.

Authors:  A H Fielder; M J Walport; J R Batchelor; R I Rynes; C M Black; I A Dodi; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-05
View more
  8 in total

1.  4-Hydroxy-7-oxo-5-heptenoic Acid Lactone Is a Potent Inducer of the Complement Pathway in Human Retinal Pigmented Epithelial Cells.

Authors:  Mikhail Linetsky; Karina S Bondelid; Sofiya Losovskiy; Vadym Gabyak; Mario J Rullo; Thomas I Stiadle; Vasu Munjapara; Priyali Saxena; Duoming Ma; Yu-Shiuan Cheng; Andrew M Howes; Emeka Udeigwe; Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2018-07-09       Impact factor: 3.739

2.  Changes in Immunity, Expression of some Immune-Related Genes of Shabot Fish, Tor grypus, Following Experimental Infection with Aeromonas hydrophila: Effects of Autochthonous Probiotics.

Authors:  Takavar Mohammadian; Mojtaba Alishahi; Mohammad Reza Tabandeh; Masoud Ghorbanpoor; Dariush Gharibi
Journal:  Probiotics Antimicrob Proteins       Date:  2018-12       Impact factor: 4.609

3.  A hapten generated from an oxidation fragment of docosahexaenoic acid is sufficient to initiate age-related macular degeneration.

Authors:  Joe G Hollyfield; Victor L Perez; Robert G Salomon
Journal:  Mol Neurobiol       Date:  2010-03-12       Impact factor: 5.590

4.  Terminal complement complexes and C1/C1 inhibitor complexes in rheumatoid arthritis and other arthritic conditions.

Authors:  D A Oleesky; R H Daniels; B D Williams; N Amos; B P Morgan
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

5.  Carboxyethylpyrroles: From Hypothesis to the Discovery of Biologically Active Natural Products.

Authors:  Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2016-11-02       Impact factor: 3.739

6.  Complement activation in neonatal infection.

Authors:  M Peakman; G Senaldi; G Liossis; H R Gamsu; D Vergani
Journal:  Arch Dis Child       Date:  1992-07       Impact factor: 3.791

7.  Oxidative damage-induced inflammation initiates age-related macular degeneration.

Authors:  Joe G Hollyfield; Vera L Bonilha; Mary E Rayborn; Xiaoping Yang; Karen G Shadrach; Liang Lu; Rafael L Ufret; Robert G Salomon; Victor L Perez
Journal:  Nat Med       Date:  2008-01-27       Impact factor: 53.440

8.  A Flow Cytometry-Based Assay for the Measurement of Total Complement Activity in the Serum and Clinical Practice.

Authors:  Xuewei Ding; Shijun Li; Hui Liu
Journal:  Dis Markers       Date:  2022-01-10       Impact factor: 3.434
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.